PCPAR1N Stock Latest News
Private CompaniesParallel Bio Strengthens AI Leadership Amid Growing Use of Drug Discovery Platform3w agoPAR1N
Private CompaniesRegulatory Shift Toward Human-First Testing Highlights Opportunity for Parallel Bio1M agoPAR1N
Private CompaniesParallel Bio Positions Human 3D Models as Solution to Drug Development Bottlenecks1M agoPAR1N
Private CompaniesParallel Bio Steps Up Positioning in AI-Driven, Non-Animal Drug Testing3M agoPAR1N
Private CompaniesParallel Bio Positions Itself in AI-Driven Drug Testing Alternatives3M agoPAR1N
Private CompaniesParallel Bio Positions Human Organoid Data for AI-Driven Drug Discovery3M agoPAR1NPrivate CompaniesRegulatory Shift Toward Non‑Animal Testing Highlights Opportunity for Parallel Bio3M agoPAR1N
Private CompaniesHuman-First Drug Testing Models Highlighted as Emerging Opportunity in Biopharma4M agoPAR1N
Private CompaniesParallel Bio Expands Bay Area Hub and Deepens Immune-Focused Drug Discovery Strategy4M agoPAR1N
Private CompaniesImmune-Focused Drug Development Strategy and Bay Area Expansion at Parallel Bio4M agoPAR1N
Private CompaniesParallel Bio Consolidates U.S. Operations with Bay Area Headquarters Hire5M agoPAR1N
Private CompaniesParallel Bio Consolidates U.S. Operations in Bay Area and Expands Advisory Bench5M agoPAR1NPrivate CompaniesParallel Bio Highlighted as World Economic Forum 2026 Technology Pioneer5M agoPAR1N
Private CompaniesParallel Bio Ramps Up Leadership Hiring to Accelerate Organoid Drug Discovery Platform5M agoPAR1N
Private CompaniesParallel Bio Expands Leadership Hiring to Advance Organoid-Based Drug Discovery5M agoPAR1N
Private CompaniesParallel Bio Steps Up Hiring to Advance Human Immune Organoid Drug Discovery Platform6M agoPAR1N
Private CompaniesParallel Bio Expands Scientific Team to Advance Human Immune Organoid Platform6M agoPAR1N
Private CompaniesParallel Bio Expands Scientific Team to Advance Human Immune Organoid Platform6M agoPAR1N

